AquaBounty defends its genetic salmon project

AquaBounty Technologies, the company that developed the GM salmon, is now having to defend its creation. The US Food and Drugs Administration (FDA) had all but agreed to allow its sale, AquaBounty Technologies CEO Ronald Stotish  said in a statement:

“We remain confident that the more deliberative body of the Senate will refrain from interfering in the 15-year scientific review by the US FDA. The facts about the safety and the environmental benefits of the fish have been made fully public by the FDA. Read more ...

This blog is written by Martin Little, The Aquaculturists, published and supported by the International Aquafeed Magazine from Perendale Publishers